![Nedjad Losic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nedjad Losic
Corporate Officer/Principal at
CANTARGIA AB
Net worth: 14 166 $ as of 31/05/2026
Profile
Nedjad Losic currently works at Cantargia AB, as Vice President-Biometrics from 2021.
Mr. Losic also formerly worked at Genmab A, as Director & Director-Biometrics from 2004 to 2013.
Mr. Losic received his graduate degree from the University of Lund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CANTARGIA AB 0.02% | 31/12/2024 | 60,000 ( 0.02% ) | 14 166 $ | 31/05/2026 |
Nedjad Losic active positions
| Companies | Position | Start |
|---|---|---|
| CANTARGIA AB | Corporate Officer/Principal | 01/09/2021 |
Former positions of Nedjad Losic
| Companies | Position | End |
|---|---|---|
| GENMAB A/S | Director/Board Member | - |
Training of Nedjad Losic
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
- Stock Market
- Insiders
- Nedjad Losic
